AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureInformation ScienceNamed GroupsHealth CareGeographicals
Treatment OutcomeNeoplasm GradingPrognosisNeoplasm StagingAntineoplastic Combined Chemotherapy ProtocolsAstrocytomaRetrospective StudiesBrain NeoplasmsSurvival AnalysisDisease-Free SurvivalSurvival RateBreast NeoplasmsFollow-Up StudiesNeoplasm Recurrence, LocalImmunohistochemistryGliomaTumor Markers, BiologicalDisease ProgressionAdenocarcinomaCombined Modality TherapyInfusions, IntravenousFluorouracilTime FactorsMaximum Tolerated DoseDeoxycytidineProspective StudiesSeverity of Illness IndexKaplan-Meier EstimateAntineoplastic AgentsCisplatinKi-67 AntigenUnited States Department of AgricultureNeutropeniaUrinary Bladder NeoplasmsPredictive Value of TestsCarcinoma, Transitional CellMeningiomaNeoplasm MetastasisProstatic NeoplasmsNeoplasm InvasivenessRisk FactorsTaxoidsOrganoplatinum CompoundsLung NeoplasmsBiopsyMultivariate AnalysisCarcinoma, Ductal, BreastCamptothecinRecurrenceLymphatic MetastasisEndometrial NeoplasmsMeningeal NeoplasmsLeucovorinKidney NeoplasmsSarcomaDose-Response Relationship, DrugLeukopeniaCarcinomaCohort StudiesRadiotherapy DosageGlioblastomaCarboplatinSalvage TherapyMitotic IndexOvarian NeoplasmsCarcinoma, Renal CellAntimetabolites, AntineoplasticEducational MeasurementMagnetic Resonance ImagingMeatCarcinoma in SituReproducibility of ResultsSensitivity and SpecificityStudentsThrombocytopeniaAge FactorsAchievementSupratentorial NeoplasmsChemotherapy, AdjuvantColorectal NeoplasmsCarcinoma, Squamous CellFeasibility StudiesDose FractionationReceptors, ProgesteroneReceptors, EstrogenAdministration, OralLymphoma, Non-HodgkinRadiation InjuriesEpendymomaGene Expression Regulation, NeoplasticImmunoenzyme TechniquesReceptor, erbB-2Antibodies, Monoclonal, HumanizedGraft vs Host DiseaseDoxorubicinAntibodies, MonoclonalVinblastineNeoplasmsProportional Hazards ModelsSoft Tissue Neoplasms